% Bibliography for hypothesis h-var-600b3e39aa
% Title: APOE4-Specific Proteolytic Fragment Inhibition Therapy
% Generated: 2026-04-28T12:12:32Z

@article{pmid40149001,
  title = {Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research.},
  author = {Jung ES, Choi H, Mook-Jung I},
  journal = {Molecular neurodegeneration},
  year = {2025},
  pmid = {40149001},
  doi = {10.1186/s13024-025-00825-0},
  url = {https://pubmed.ncbi.nlm.nih.gov/40149001/},
}

@article{pmid39232848,
  title = {Updates in Alzheimer's disease: from basic research to diagnosis and therapies.},
  author = {Liu E, Zhang Y, Wang JZ},
  journal = {Translational neurodegeneration},
  year = {2024},
  pmid = {39232848},
  doi = {10.1186/s40035-024-00432-x},
  url = {https://pubmed.ncbi.nlm.nih.gov/39232848/},
}

@article{pmid39232848,
  title = {Updates in Alzheimer's disease: from basic research to diagnosis and therapies.},
  author = {Liu E, Zhang Y, Wang JZ},
  journal = {Transl Neurodegener},
  year = {2024},
  pmid = {39232848},
  doi = {doi: 10.1186/s40035-024-00432-x},
  url = {https://pubmed.ncbi.nlm.nih.gov/39232848/},
}

@article{pmid35232622,
  title = {APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.},
  author = {Parhizkar S, Holtzman DM},
  journal = {Seminars in immunology},
  year = {2022},
  pmid = {35232622},
  doi = {10.1016/j.smim.2022.101594},
  url = {https://pubmed.ncbi.nlm.nih.gov/35232622/},
}

@article{pmid33958804,
  title = {Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease.},
  author = {Zalocusky KA, Najm R, Taubes AL, Hao Y, Yoon SY, Koutsodendris N, Nelson MR, Rao A, Bennett DA, Bant J, Amornkul DJ, Xu Q, An A, Cisne-Thomson O, Huang Y},
  journal = {Nature neuroscience},
  year = {2021},
  pmid = {33958804},
  doi = {10.1038/s41593-021-00851-3},
  url = {https://pubmed.ncbi.nlm.nih.gov/33958804/},
}